News
-
Protected: Novel Biosensing and VOC Data Standards Meeting
There is no excerpt because this is a protected post.
-
Protected: Novel Biosensor Kickoff Meeting
There is no excerpt because this is a protected post.
-
A Rapid Saliva Antigen Test for SARS-CoV-2 Detection
Abstract Text: The pandemic caused by COVID-19 has been associated with a very high disease burden as well as high global financial costs. With this pandemic came massive shut downs of both private and public businesses including schools, retail stores, and restaurants. In order to be able to safely open these places of business and…
-
Virus Counter: Rapid and Sensitive Diagnostics Based on Digital Detection of Individual Pathogens
Abstract Text: The breakneck spread of 2019 novel coronavirus (SARS-CoV-2) has exposed the soft underbelly of modern infectious disease diagnostics – a system highly reliant on PCR-based diagnosis. In this pandemic, the system has been rapidly overwhelmed, as it was in the 2009 pandemic flu and the 2014-6 Ebola outbreak. Other approaches for the detection…
-
RADx-rad: A Rapid, Sensitive, Point-of-care, Antigen-based Diagnostics for SARS-CoV-2
Abstract Text: A rapid, sensitive, low-cost diagnostic device for early detection of novel Coronavirus Disease (COVID-19) can significantly change the paradigm in real-time and efficient management of patients and available healthcare resources specifically during this time of increased demand for hospital services. The quantitative real-time polymerase chain reaction (qPCR) represents the most important method for…
-
A Rapid Breathalyzer Diagnostics Platform for COVID-19
Abstract Text: The Rutgers Optimizes Innovation (ROI) Program will provide a vertically integrated mechanism to swiftly uncover promising biomedical product discoveries, and seamlessly guide the innovator through the commercialization process with financial and regulatory, IP protection, mentoring, management, and educational resources. Drawing on the biomedical/bioengineering sciences across Rutgers and on the solid expertise of the…
-
A SARS-CoV-2 Breathalyzer for Direct Virus Detection
Abstract Text: A substantial and growing body of evidence has demonstrated that COVID-19 is transmitted by human-emitted airborne particles; therefore, it is critical to rapidly screen individuals to determine whether they are at risk of transmitting the disease to others before they enter large venues (e.g., airports, schools) and smaller ones where extended exposure or…
-
Designer DNA Nanostructure Based Biosensing for Rapid COVID-19 Detection and Monitoring using Saliva Sample
Abstract Text: A Novel Saliva-Based Aptamer Detection Assay for SARS-CoV-2 Infection (RFA-OD-20-021 STTR Application) Automated, rapid diagnostics with little sample collection and preparation are needed to identify and trace affected persons in times when hyper-infectious pathogens cause pandemics. Frequent, low cost and highly scalable testing is the only way to gain visibility on the magnitude…
-
Broad-spectrum Detection of VOC and Non-VOC Biomarkers from Patient Exhalant using Biomimetic Multiplexed eNose Biosensor for COVID-19 Diagnosis
Abstract Text: The overarching goal of the partnership between NIH and the University of Washington (UW) Entrepreneurial Center for Research Evaluation and Commercialization Hub (referred to as WE-REACH) is to facilitate and accelerate the transformation of health research innovations into products. This NIH funded WE-REACH Center is a National Center of REACH in the Northwest…
-
MOF-SCENT: Metal-organic Frameworks for Screening COVID-19 by Electronic-Nose Technology to Improve Selectivity and Time Response
Abstract Text: The goal of this project is to establish robust, proof-of-concept feasibility for an innovative E-nose system, termed the MOF-SCENT system, for real-time and non-invasive screening for asymptomatic and symptomatic COVID-19 patients, with high accuracy based on the detection of VOCs emanating from exhaled breath. The proposed OE-HCCR-MOF based E-nose sensor is a novel…